Overall Status

Completed (17)

Unknown status (6)

Recruiting (2)

Terminated (2)

Withdrawn (1)

Phase

phase 2 (9)

phase 3 (7)

phase 4 (4)

n/a (3)

phase 2/phase 3 (3)

early phase 1 (2)

Collaborator

Canadian Institutes of Health Research (CIHR) (2)

Hanmi Pharmaceutical Company Limited (1)

IlDong Pharmaceutical Co Ltd (1)

National Cancer Institute (NCI) (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Tanta University (1)

The Gerber Foundation (1)

Study Documents

Intervention Type

drug (28)

other (4)

dietary supplement (1)

procedure (1)

Funder Type

Other (23)

Industry (3)

NIH (2)

Study Type

Interventional (28)

l-carnitine

Showing 26 - 28 of 28

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

End-Stage Renal Disease Trial in Chieti (L-carnitine)

Completed

Has Results

End-Stage Renal Disease

L-carnitine

Chieti, Italy

Division of Nephrology, University of "G. d'Annunzio"

Feb 16, 2010

HIV, AIDS Trial in New York (L-carnitine, Placebo)

Completed

HIV Infections
AIDS

L-carnitine
Placebo

New York, New York

Department of Pain Medicine and Palliative Care; Beth Israel Med

Sep 2, 2008

Tumors Trial in New York (L-carnitine)

Completed

Neoplasms

L-carnitine

New York, New York

Beth Israel Medical Center

Aug 17, 2006